Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism (Q37622058)

21 August 2017

1 reference

title

Possible renoprotection by vitamin D in chronic renal disease: beyond mineral metabolism (English)

1 reference

21 August 2017

0 references

0 references

chronic renal disease

1 reference

inferred from title

author name string

Carolina R C Doorenbos

1

1 reference

21 August 2017

Jacob van den Born

2

1 reference

21 August 2017

Gerjan Navis

3

1 reference

21 August 2017

Martin H de Borst

4

1 reference

21 August 2017

language of work or name

English

0 references

publication date

27 October 2009

1 reference

Nature Reviews Nephrology

21 August 2017

1 reference

21 August 2017

5

1 reference

21 August 2017

691-700

1 reference

21 August 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneph.2009.185

21 August 2017

0 references

cites work

Genomic mechanisms involved in the pleiotropic actions of 1,25-dihydroxyvitamin D3.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1alpha,25-dihydroxy-vitamin D3 stimulation of bronchial smooth muscle cells induces autocrine, contractility, and remodeling processes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Megalin knockout mice as an animal model of low molecular weight proteinuria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

An endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Calcitonin, a regulator of the 25-hydroxyvitamin D3 1alpha-hydroxylase gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Selective use of multiple vitamin D response elements underlies the 1 alpha,25-dihydroxyvitamin D3-mediated negative regulation of the human CYP27B1 gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Klotho converts canonical FGF receptor into a specific receptor for FGF23

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Profiling 1,25-dihydroxyvitamin D3-regulated gene expression by microarray analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

The vitamin D3 transcriptomic response in skin cells derived from the Atlantic bottlenose dolphin.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Identification of VDR-responsive gene signatures in breast cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Paricalcitol inhibits renal inflammation by promoting vitamin D receptor-mediated sequestration of NF-kappaB signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Minireview: vitamin D receptor: new assignments for an already busy receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Resurrection of vitamin D deficiency and rickets

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-Dihydroxyvitamin D3 targeting of NF-kappaB suppresses high glucose-induced MCP-1 expression in mesangial cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Renoprotective role of the vitamin D receptor in diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

The role of vitamin D in the prevention of osteoporosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Which circulating level of 25-hydroxyvitamin D is appropriate?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Redefining vitamin D insufficiency

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Pharmacokinetics of vitamin D toxicity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Sunscreens suppress cutaneous vitamin D3 synthesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Frequency of leisure-time physical activity and serum 25-hydroxyvitamin D levels in the US population: results from the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Decreased bioavailability of vitamin D in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Are clinical laboratories prepared for accurate testing of 25-hydroxy vitamin D?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Interlaboratory variation in 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 is significantly improved if common calibration material is used

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Serum 25-hydroxyvitamin D status of the US population: 1988-1994 compared with 2000-2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

25-Hydroxyvitamin D assays: the quest for accuracy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D deficiency and associated factors in hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D affects survival independently of vascular calcification in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D status of chronic kidney disease patients living in a sunny country

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D levels and early mortality among incident hemodialysis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Serum 25-hydroxyvitamin D status and cardiovascular outcomes in chronic peritoneal dialysis patients: a 3-y prospective cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D deficiency and mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

25-hydroxyvitamin D levels and the risk of mortality in the general population

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D deficiency and risk of cardiovascular disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Independent association of low serum 25-hydroxyvitamin d and 1,25-dihydroxyvitamin d levels with all-cause and cardiovascular mortality

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Calcium/vitamin D supplementation and cardiovascular events

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Letter by Wallis and Penckofer regarding article, "Calcium/vitamin D supplementation and cardiovascular events"

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D Deficiency and Nutritional Rickets in Children

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D3 and calcium to prevent hip fractures in elderly women

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

25-Hydroxyvitamin D levels and albuminuria in the Third National Health and Nutrition Examination Survey (NHANES III)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

The selective vitamin D receptor activator for albuminuria lowering (VITAL) study: study design and baseline characteristics.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Relationship between serum 1,25-dihydroxyvitamin D and mortality in patients with pre-dialysis chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D levels and patient outcome in chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

25-Hydroxyvitamin D, insulin resistance, and kidney function in the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Long-term bone loss in kidney transplant recipients: a cross-sectional and longitudinal study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Paricalcitol attenuates renal interstitial fibrosis in obstructive nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Active vitamin D and its analogue, 22-oxacalcitriol, ameliorate puromycin aminonucleoside-induced nephrosis in rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Defective Photoproduction of Cholecalciferol in Normal and Uremic Humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effect of 1,25 (OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-Dihydroxyvitamin D(3) prevents puromycin aminonucleoside-induced apoptosis of glomerular podocytes by activating the phosphatidylinositol 3-kinase/Akt-signaling pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Induction of nephrin gene expression by selective cooperation of the retinoic acid receptor and the vitamin D receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Screening and identification of substances that regulate nephrin gene expression using engineered reporter podocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Altered vitamin D metabolism in type II diabetic mouse glomeruli may provide protection from diabetic nephropathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-Dihydroxyvitamin D3decreases podocyte loss and podocyte hypertrophy in the subtotally nephrectomized rat

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin D status and arterial hypertension: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1,25-dihydroxyvitamin D3 modulation of adipocyte glucocorticoid function.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Specific MAP-kinase blockade protects against renal damage in homozygous TGR(mRen2)27 rats

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

High- versus low-dose ACE inhibition in chronic heart failure: a double-blind, placebo-controlled study of imidapril.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Benefits of dietary sodium restriction in the management of chronic kidney disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effect of combining ACE inhibition with aldosterone blockade on proteinuria and renal damage in experimental nephrosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

ACE inhibition has adverse renal effects during dietary sodium restriction in proteinuric and healthy rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Renal and systemic effects of continued treatment with renin inhibitor remikiren in hypertensive patients with normal and impaired renal function

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Aliskiren combined with losartan in type 2 diabetes and nephropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Renal effects of aliskiren compared with and in combination with irbesartan in patients with type 2 diabetes, hypertension, and albuminuria

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Aliskiren enhances the protective effects of valsartan against cardiovascular and renal injury in endothelial nitric oxide synthase-deficient mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Aliskiren-binding increases the half life of renin and prorenin in rat aortic vascular smooth muscle cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: blockade of compensatory renin increase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Inter-individual differences in anti-proteinuric response to ACEi in established adriamycin nephrotic rats are predicted by pretreatment renal damage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1 alpha,25-dihydroxyvitamin D3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Reduction of the vitamin D hormonal system in kidney disease is associated with increased renal inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

The anti-inflammatory activity of 1,25-dihydroxyvitamin D3 in macrophages

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

DCs metabolize sunlight-induced vitamin D3 to 'program' T cell attraction to the epidermal chemokine CCL27

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Regulation of 25-hydroxyvitamin D3-1 alpha-hydroxylase and production of 1 alpha,25-dihydroxyvitamin D3 by human dendritic cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Vitamin effects on the immune system: vitamins A and D take centre stage

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Expansion of antigen-specific regulatory T cells with the topical vitamin d analog calcipotriol.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

1alpha,25-dihydroxyvitamin D3 shows strong and additive immunomodulatory effects with cyclosporine A in rat renal allotransplants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Effects of vitamin D supplementation on the calcium-phosphate balance in renal transplant patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

Kidney dendritic cell activation is required for progression of renal disease in a mouse model of glomerular injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

VITA-D: cholecalciferol substitution in vitamin D deficient kidney transplant recipients: a randomized, placebo-controlled study to evaluate the post-transplant outcome.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2009.185

A genomic perspective on vitamin D signaling

31 March 2020

1 reference

12 December 2020

Immunolocalization of calcitriol receptor, 24-hydroxylase cytochrome P-450, and calbindin D28k in human kidney

1 reference

12 December 2020

Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism

1 reference

12 December 2020

Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis

1 reference

12 December 2020

Combining an antiproteinuric approach with mycophenolate mofetil fully suppresses progressive nephropathy of experimental animals

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2009.185

1 reference

21 August 2017

1 reference